Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson’s disease-Reference-Cited by-同舟云学术

Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson’s disease

Published:2006-09 Issue:9 Volume:253 Page:1154-1159
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Dujardin Kathy,Devos David,Duhem Stéphane,Destée Alain,Marié Rose-Marie,Durif Franck,Lacomblez Lucette,Touchon Jacques,Pollak Pierre,Péré Jean-Jacques

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1007/s00415-006-0175-2.pdf

Reference25 articles.

1. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P (2003) Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 60: 387–92

2. Aarsland D, Mosimann UP, McKeith IG (2004) Role of cholinesterase inhibitors in Parkinson’s disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 17:164–71

3. Bak TH, Rogers TT, Crawford LM, Hearn VC, Mathuranath PS, Hodges JR (2005) Cognitive bedside assessment in atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry 76: 420–2

4. Bohnen NI, Kaufer DI, Ivanco LS, Lopresti B, Koeppe RA, Davis JG, Mathis CA, Moore RY, Dekosky ST (2003) Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol 60:1745–8

5. Bohnen NI, Kaufer DI, Hendrickson R, Ivanco LS, Lopresti BJ, Constantine GM, Mathis CA, Davis JG, Moore RY, Dekosky ST (2005) Cognitive correlates of cortical cholinergic denervation in Parkinson’s disease and parkinsonian dementia. J Neurol Sep 2; [Epub ahead of print]

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cognitive dysfunction in animal models of human lewy-body dementia;Frontiers in Aging Neuroscience;2024-07-22

2. Current concepts in treating mild cognitive impairment in Parkinson's disease;Neuropharmacology;2022-02

3. Anatomical predictors of cognitive decline after subthalamic stimulation in Parkinson’s disease;Brain Structure and Function;2018-05-07

4. Global scales for cognitive screening in Parkinson's disease: Critique and recommendations;Movement Disorders;2017-11-23

5. Rivastigmine for mild cognitive impairment in Parkinson disease: A placebo-controlled study;Movement Disorders;2015-04-25